Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer.
Morante Z, Ferreyra Y, Pinto JA, Valdivieso N, Castañeda C, Vidaurre T, Valencia G, Rioja P, Fuentes H, Cotrina JM, Neciosup S, Gomez HL. Morante Z, et al. Among authors: fuentes h. Front Oncol. 2023 Nov 6;13:1193927. doi: 10.3389/fonc.2023.1193927. eCollection 2023. Front Oncol. 2023. PMID: 38023174 Free PMC article.
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
González-Rivera M, Lobo M, López-Tarruella S, Jerez Y, Del Monte-Millán M, Massarrah T, Ramos-Medina R, Ocaña I, Picornell A, Santillán Garzón S, Pérez-Carbornero L, García-Saenz JA, Gómez H, Moreno F, Márquez-Rodas I, Fuentes H, Martin M. González-Rivera M, et al. Among authors: fuentes h. Breast Cancer Res Treat. 2016 Apr;156(3):507-515. doi: 10.1007/s10549-016-3792-1. Epub 2016 Apr 15. Breast Cancer Res Treat. 2016. PMID: 27083178
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
González-Rivera M, Lobo M, López-Tarruella S, Jerez Y, Del Monte-Millán M, Massarrah T, Ramos-Medina R, Ocaña I, Picornell A, Santillán Garzón S, Pérez-Carbornero L, García-Saenz JA, Gómez H, Moreno F, Márquez-Rodas I, Fuentes H, Martin M. González-Rivera M, et al. Among authors: fuentes h. Breast Cancer Res Treat. 2017 Sep;165(2):471. doi: 10.1007/s10549-017-4396-0. Breast Cancer Res Treat. 2017. PMID: 28721639 No abstract available.
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification.
Echavarria I, López-Tarruella S, Picornell A, García-Saenz JÁ, Jerez Y, Hoadley K, Gómez HL, Moreno F, Monte-Millan MD, Márquez-Rodas I, Alvarez E, Ramos-Medina R, Gayarre J, Massarrah T, Ocaña I, Cebollero M, Fuentes H, Barnadas A, Ballesteros AI, Bohn U, Perou CM, Martin M. Echavarria I, et al. Among authors: fuentes h. Clin Cancer Res. 2018 Apr 15;24(8):1845-1852. doi: 10.1158/1078-0432.CCR-17-1912. Epub 2018 Jan 29. Clin Cancer Res. 2018. PMID: 29378733 Free PMC article.
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.
Marker KM, Zavala VA, Vidaurre T, Lott PC, Vásquez JN, Casavilca-Zambrano S, Calderón M, Abugattas JE, Gómez HL, Fuentes HA, Picoaga RL, Cotrina JM, Neciosup SP, Castañeda CA, Morante Z, Valencia F, Torres J, Echeverry M, Bohórquez ME, Polanco-Echeverry G, Estrada-Florez AP, Serrano-Gómez SJ, Carmona-Valencia JA, Alvarado-Cabrero I, Sanabria-Salas MC, Velez A, Donado J, Song S, Cherry D, Tamayo LI, Huntsman S, Hu D, Ruiz-Cordero R, Balassanian R, Ziv E, Zabaleta J, Carvajal-Carmona L, Fejerman L; COLUMBUS Consortium. Marker KM, et al. Cancer Res. 2020 May 1;80(9):1893-1901. doi: 10.1158/0008-5472.CAN-19-3659. Epub 2020 Apr 3. Cancer Res. 2020. PMID: 32245796 Free PMC article.
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
De-la-Cruz-Ku G, Luyo M, Morante Z, Enriquez D, Möller MG, Chambergo-Michilot D, Flores L, Luque R, Saavedra A, Eyzaguirre-Sandoval ME, Luján-Peche MG, Noel N, Calderon H, Razuri C, Fuentes HA, Cotrina JM, Neciosup SP, Araujo J, Lema A, Pinto J, Gomez HL, Valcarcel B. De-la-Cruz-Ku G, et al. Among authors: fuentes ha. PLoS One. 2020 Aug 24;15(8):e0237811. doi: 10.1371/journal.pone.0237811. eCollection 2020. PLoS One. 2020. PMID: 32833983 Free PMC article.
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
Morante Z, Ruiz R, Araujo JM, Pinto JA, Cruz-Ku G, Urrunaga-Pastor D, Namuche F, Flores C, Mantilla R, Luján MG, Fuentes H, Schwarz L, Aguilar A, Neciosup S, Gómez HL. Morante Z, et al. Among authors: fuentes h. Clin Breast Cancer. 2021 Jun;21(3):239-246.e4. doi: 10.1016/j.clbc.2020.09.008. Epub 2020 Sep 18. Clin Breast Cancer. 2021. PMID: 33221201
COVID-19 in cancer patients: a systematic review.
Castañeda CA, Castillo M, Rojas-Vilca JL, Fuentes H, Gómez HL. Castañeda CA, et al. Among authors: fuentes h. Rev Peru Med Exp Salud Publica. 2020 Oct-Dec;37(4):611-619. doi: 10.17843/rpmesp.2020.374.5976. Epub 2021 Feb 3. Rev Peru Med Exp Salud Publica. 2020. PMID: 33566899 English, Spanish.
A biomarker study in Peruvian males with breast cancer.
Castaneda CA, Castillo M, Bernabe LA, Sanchez J, Torres E, Suarez N, Tello K, Fuentes H, Dunstan J, De La Cruz M, Cotrina JM, Abugattas J, Guerra H, Gomez HL. Castaneda CA, et al. Among authors: fuentes h. World J Clin Oncol. 2021 Oct 24;12(10):926-934. doi: 10.5306/wjco.v12.i10.926. World J Clin Oncol. 2021. PMID: 34733614 Free PMC article.
74 results